title: Levodopa: why the controversy?
authors.forename: Y
authors.initials: Y
authors.lastname: Agid
authors.forename: C W
authors.initials: CW
authors.lastname: Olanow
authors.forename: Y
authors.initials: Y
authors.lastname: Mizuno
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa